7%), but chest pain was rarely presented (3.4%).
Although, prodromal symptoms themselves were not associated with better neurological outcomes (adjusted odds ratio [AOR], 2.03; 95% confidence interval [CI], 1.00-4.13), earlier contact to a patient yielded better neurological outcomes (AOR per every one-minute increase, 0.90; 95% CI, 0.82-0.99).
Conclusions: Many of OHCA regardless of etiology have prodromal symptoms before arrest. Prodromal symptoms induced early activation of the EMS system, and may thus improve outcomes after OHCA. (C) 2012 Elsevier Ireland Ltd. All rights reserved.”
“OBJECTIVE: To compare the estimated proportion of contraindications to combined oral contraceptives between women who obtained combined oral contraceptives in U.S. this website public clinics compared with women who obtained combined oral contraceptives over the counter (OTC) in Mexican pharmacies.
METHODS: We recruited a cohort of 501 women who were residents of El Paso, Texas, who obtained OTC combined oral contraceptives in Mexico and 514 women who obtained combined oral contraceptives from family planning clinics in El Paso. Based on self-report of World Health Organization category 3 and 4 contraindications and interviewer-measured blood pressure, we estimated the proportion of contraindications and, using multivariable-adjusted logistic regression, identified possible predictors of contraindications.
RESULTS: The estimated proportion of any category
3 or 4 contraindication was 18%. Relative contraindications (category 3) were more common among OTC users (13% compared with 9% among BYL719 ic50 clinic users, P=.006). Absolute contraindications (category 4) were not different between the groups (5% for clinic users compared with 7% for OTC users, P=.162). Hypertension was the most prevalent contraindication (5.6% of clinic users and 9.8% of OTC users). After multivariable adjustment, OTC users had higher odds of having contraindications compared with clinic users (odds ratio [OR] 1.59, 95% confidence interval [CI] 1.11-2.29). Women aged 35
years or older (OR 5.30, 95% CI 3.59-7.81) and those with body mass index 30.0 or more (OR 2.24, 95% CI 1.40-3.56) also had higher odds of having contraindications.
CONCLUSION: HKI-272 cell line Relative combined oral contraceptive contraindications are more common among OTC users in this setting. Progestin-only pills might be a better candidate for the first OTC product given their fewer contraindications. (Obstet Gynecol 2011;117:558-65) DOI:10.1097/AOG.0b013e31820b0244″
“Purpose of review
To understand all of the current options available to treat glucose intolerance in pregnancy.
Recent findings
Recent attention to the use of oral agents in the treatment of gestational diabetes remains controversial. This review will outline the advantages and disadvantages, as well as safety profiles of two classes of oral mediations.
Summary
There are many effective treatments for gestational diabetes.